ENTRY       D10438                      Drug
NAME        Guselkumab (USAN/INN);
            Guselkumab (genetical recombination) (JAN);
            Tremfya (TN)
PRODUCT     TREMFYA (Janssen Biotech)
FORMULA     C6402H9864N1676O1994S42
EXACT_MASS  143471.0249
MOL_WEIGHT  143559.5844
SEQUENCE    (Heavy chain)
            EVQLVQSGAE VKKPGESLKI SCKGSGYSFS NYWIGWVRQM PGKGLEWMGI IDPSNSYTRY
            SPSFQGQVTI SADKSISTAY LQWSSLKASD TAMYYCARWY YKPFDVWGQG TLVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELLGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSRDELTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Light chain)
            QSVLTQPPSV SGAPGQRVTI SCTGSSSNIG SGYDVHWYQQ LPGTAPKLLI YGNSKRPSGV
            PDRFSGSKSG TSASLAITGL QSEDEADYYC ASWTDGLSLV VFGGGTKLTV LGQPKAAPSV
            TLFPPSSEEL QANKATLVCL ISDFYPGAVT VAWKADSSPV KAGVETTTPS KQSNNKYAAS
            SYLSLTPEQW KSHRSYSCQV THEGSTVEKT VAPTECS
            (Disulfide bridge: H22-H96, H144-H200, H220-L216, H226-H'226, H229-H'229, H261-H321, H367-H425, H'22-H'96, H'144-H'200, H'220-L'216, H'261-H'321, H'367-H'425, L22-L90, L139-L198, L'22-L'90, L'139-L'198; Modified residue: L1, L'1 Q=pyroglutamic acid [CPD:C01879]; Glycosylation site: Asn-297, Asn-297'')
  TYPE      Peptide
CLASS       Immunological agent
             DG02019  Interleukin inhibitor
REMARK      Therapeutic category: 3999
            ATC code: L04AC16
            Product: D10438<JP/US>
EFFICACY    Antipsoriatic, Anti-IL-23 antibody
  DISEASE   Plaque psoriasis [DS:H01656]
  TYPE      Monoclonal antibody
COMMENT     Treatment of inflammatory diseases, psoriasis
TARGET      IL23A [HSA:51561] [KO:K05426]
  PATHWAY   hsa04060(51561)  Cytokine-cytokine receptor interaction
            hsa04630(51561)  JAK-STAT signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AC Interleukin inhibitors
                 L04AC16 Guselkumab
                  D10438  Guselkumab (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Immunological Agents, Other
               Interleukin Blockers
                Guselkumab
                 D10438  Guselkumab (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D10438  Guselkumab (USAN/INN); Guselkumab (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Immunological agent
              DG02019  Interleukin inhibitor
               D10438  Guselkumab
            Drug classes [BR:br08332]
             Immunological agent
              DG02019  Interleukin inhibitor
               D10438  Guselkumab
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interleukins
                IL23A
                 D10438  Guselkumab (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10438
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10438
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10438
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10438
DBLINKS     CAS: 1350289-85-8
            PubChem: 172232531
///
